[The effects of N-propyl-ajmaline hydrogen tartrate (NPAB), SPARTEINE SULFATE (SPARteine) and NPAB + sparteine on ECG and aconitine arrhythmias of SIV-rats].
D031841:Aconitum; D000284:Administration, Oral; D000404:Ajmaline / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002415:Cats; D002463:Cell Membrane Permeability / Q000187:drug effects; D003864:Depression, Chemical; D004285:Dogs; D004336:Drug Antagonism; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D004562:Electrocardiography; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D008297:Male; D008722:Methods; D051381:Rats; D013034:Sparteine / Q000494:pharmacology* / Q000627:therapeutic use; D013644:Tartrates / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D013644:Tartrates; D000404:Ajmaline; D013034:Sparteine